Search - tctmd.com

Displaying 681 - 700 of 849

Sort: Relevancy | Date

News Daily News

Risk of Intracranial Hemorrhage, Mortality Lower with Dabigatran in A-fib Patients

L.A. McKeown

April 30, 2012

News Daily News

El Riesgo de Hemorragia Intracraneal y Mortalidad es Más Bajo con Dabigatran en Pacientes que Padecen Fibrilación Auricular

L.A. McKeown

April 30, 2012

News Daily News

PCI Capability Matters More Than Academic Affiliation for STEMI Survival

Leah Lawrence

April 26, 2012

News Daily News

La Capacitación para realizar PCI es Más Importante que la Afiliación Universitaria para la Supervivencia de los Pacientes que sufren un STEMI

Leah Lawrence

April 26, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

Cambiar a Estatinas No Metabolizadas por CYP3A4 podría Reducir la Alta Reactividad Plaquetaria

April 25, 2012

News Daily News

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Jason Kahn

April 17, 2012

News Daily News

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

Jason Kahn

April 17, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

Análisis Genético CHARISMA: Las Variantes del CYP2C19 Influyen Poco a Nivel Clínico

April 10, 2012

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

L.A. McKeown

April 04, 2012

News Daily News

La Anemia de Base Aumenta el Riesgo de Trombosis del Stent tras la Colocación de un SLF

L.A. McKeown

April 04, 2012

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Daily News

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

April 03, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Industry News

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

March 26, 2012

News Conference News ACC 2012

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

L.A. McKeown

March 25, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

Advertisement

Risk of Intracranial Hemorrhage, Mortality Lower with Dabigatran in A-fib Patients

El Riesgo de Hemorragia Intracraneal y Mortalidad es Más Bajo con Dabigatran en Pacientes que Padecen Fibrilación Auricular

PCI Capability Matters More Than Academic Affiliation for STEMI Survival

La Capacitación para realizar PCI es Más Importante que la Afiliación Universitaria para la Supervivencia de los Pacientes que sufren un STEMI

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

Cambiar a Estatinas No Metabolizadas por CYP3A4 podría Reducir la Alta Reactividad Plaquetaria

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Análisis Genético CHARISMA: Las Variantes del CYP2C19 Influyen Poco a Nivel Clínico

Baseline Anemia Raises Risk for Stent Thrombosis After DES

La Anemia de Base Aumenta el Riesgo de Trombosis del Stent tras la Colocación de un SLF

PRODIGY Published: No Advantage to Long-term Clopidogrel

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content